Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 740-746

  Junyent, Mireia ^a,b   Zambón, Daniel ^a,b   Gilabert, Rosa ^a   Cofán, Montserrat ^a,b   Núñez, Isabel ^a,b   Ros, Emilio ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Apolipoprotein B apolipoprotein A I ratio; Carotid IMT; Carotid plaque; Familial combined hyperlipidemia; Metabolic syndrome; Sonography

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 41249097560     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.07.008     Document Type: Article

References (32)

1. Hopkins P., Heiss G., Ellison C., et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia. A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108 (2003) 519-523
2. Goldstein J.L., Schrott H.G., Hazzard W.R., Bierman E.L., and Motulsky A.G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
3. Genest Jr. J.J., Martin-Munley S.S., McNamara J.R., et al. Familial lipoprotein disorders in patients with premature coronary heart disease. Circulation 85 (1992) 2025-2033
4. Voors-Pette C., and de Bruin T.W.A. Excess coronary heart disease, cardiac risk factors and central obesity in familial combined hyperlipidemia (FCHL). Atherosclerosis 157 (2001) 481-489
5. Austin M.A., McKnight B., Edwards K.L., et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101 (2000) 2777-2782
6. Veerkamp M.J., de Graaf J., Hendriks J., Demacker P., and Stalenhoef A.F. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 109 (2004) 2980-2985
7. Carr M.C., and Brunzell J.D. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 89 (2004) 2601-2607
8. van der Kallen C.J.H., Voors-Pette C., and de Bruin T.W.A. Abdominal obesity and expression of familial combined hyperlipidemia. Obes Res 12 (2004) 2054-2061
9. O'Leary D.H., and Polak J.F. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90 (2002) 18-21
10. Keulen E.T., Kruijshoop M., Schaper N.C., Hoeks A.P., and Bruin T.W. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B. Arterioscler Thromb Vasc Biol 22 (2002) 283-288
11. Liu M.L., Ylitalo K., Salonen R., Salonen J.T., and Taskinen M.R. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol 24 (2004) 1492-1497
12. Halenka M., Vaverkova H., Hutra M., et al. Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia. Int Angiol 23 (2004) 230-237
13. ter Avest E., Holewijn S., Bredie S.J., Stalenhoef A.F., and de Graaf J. Remnant particles are the major determinant of an increased intima-media thickness in patients with familial combined hyperlipidemia (FCH). Atherosclerosis 191 (2007) 220-226
14. Walldius G., and Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy. A review of the evidence. J Intern Med 259 (2006) 493-519
15. Spence D.J. Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol 89 Suppl (2002) 10B-16B
16. Störk S., van den Beld A.W., von Schacky C., et al. Carotid artery plaque burden, stiffness, and mortality risk in elderly men. A prospective, population-based cohort study. Circulation 110 (2004) 344-348
17. Gomez-Gerique J.A., Gutierrez-Fuentes J.A., Montoya M.T., et al. Lipid profile of the Spanish population: the DRECE (Diet and Risk of Cardiovascular Disease in Spain) study. DRECE study group. Med Clin (Barc) 113 (1999) 730-735
18. Junyent M., Gilabert R., Zambón D., et al. The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias. Arterioscler Thromb Vasc Biol 25 (2005) 2203-2208
19. Pocovi M., Civeira F., Alonso R., and Mata P. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. Semin Vasc Med 4 (2004) 67-74
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143-421.
21. Junyent M., Cofán M., Nuñez I., et al. Influence of the HDL cholesterol level on preclinical carotid atherosclerosis in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 26 (2006) 1107-1113
22. Riley W.A. Cardiovascular risk assessment in individual patients from carotid intimal-media thickness measurements. Curr Atheroscler Rep 6 (2004) 225-231
23. Sniderman A.D., Castro Cabezas M., Ribalta J., et al. A proposal to redefine familial combined hyperlipidaemia-third workshop on FCHL held in Barcelona from 3-5 May 2001, during the Scientific Sessions of the European Society for Clinical Investigation. Eur J Clin Invest 32 (2002) 71-73
24. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., et al. for the WHO MONICA Project. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355 (2000) 675-687
25. Pérez G., Pena A., Sala J., et al. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. Int J Epidemiol 27 (1998) 599-604
26. Manolio T.A., Boerwinkle E., O'Donnell C.J., and Wilson A.F. Genetics of ultrasonographic carotid atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 1567-1577
27. Hulthe J., Bokemark L., Wikstrand J., and Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 20 (2000) 2140-2147
28. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Diabetes Care 26 (2003) 1251-1257
29. Tzou W.S., Douglas P.S., Srinivasan S.R., et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome. The Bogalusa Heart Study. J Am Colloid Cardiol 46 (2005) 457-463
30. Purnell J.Q., Kahn S.E., Schwartz R.S., and Brunzell J.D. Relationship of insulin sensitivity and ApoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 21 (2001) 567-572
31. Sniderman A.D., Furberg C.D., Keech A., et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361 (2003) 777-780
32. Wallenfeldt K., Bokemark L., Wikstrand J., Hulthe J., and Fagerberg B. Apolipoprotein B/Apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35 (2004) 2248-2252